The average one-year price target for Larimar Therapeutics (NasdaqGM:LRMR) has been revised to $16.97 / share. This is a ...
Larimar is a rare blue mineral found only in the Dominican Republic that has exploded in popularity in recent years. CBS News' Meg Oliver talks to artisans who shape the stone into jewelry and reports ...
BALA CYNWYD, Pa., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
As of June 30, 2025, the Company had cash, cash equivalents and marketable securities totaling $138.5 million. Together with net proceeds of approximately $65.1 million from the July 2025 public ...
BALA CYNWYD, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
Larimar Therapeutics recently announced positive results from its long-term open label study of nomlabofusp in participants with Friedreich's Ataxia, showing benefits at both 25 mg and 50 mg doses ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Larimar Therapeutics ( (LRMR)) has shared ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Larimar Therapeutics reports ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback